我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

进展期近端胃癌根治术联合脾脏切除术适应证的选择(PDF)

《中国普外基础与临床杂志》[ISSN:1007-9424/CN:51-1505/R]

期数:
2010年01期
页码:
22-24
栏目:
专题
出版日期:
2010-01-25

文章信息/Info

Title:
 Indication of Splenectomy in Radical Resection for Advanced Proximal Gastric Cancer
稿件编号:
201001006
作者:
崔超; 孙立波; 舒振波; 李永超; 丁大勇; 冯野; 盖保东; 金殷植; 赵吉生; 郑泽霖
 吉林大学中日联谊医院胃肠外科（长春 130033）
Author(s):
 CUI Chao;  SUN Li-bo;  SHU Zhen-bo;  LI Yong-chao;  DING Da-yong;  FENG Ye;  GAI Bao-dong;  JIN Yin-Zhi; 
ZHAO Ji-sheng;  ZHENG Ze-lin
 Department of Gastrointestinal Surgery, China-Japan Union Hospital, Jilin University, Changchun 130033, China
关键词:
 ; 近端胃癌;  根治术;  脾切除;  适应证
Keywords:
 ; Proximal gastric cancer;  Radical resection;  Splenectomy;  Indication
分类号:
R656.61; R735.2
DOI:
-
文献标识码:
A
摘要:
目的 探讨进展期近端胃癌根治术联合脾脏切除术的合理适应证。
方法 选取我院自2005年3月至2008年2月期间50例进展期近端胃癌行全胃切除患者为研究对象，根据脾脏是否切除分为切脾组（n=18）和保脾组（n=32）,比较2组患者间手术时间、住院时间、术后并发症以及脾门淋巴结转移情况。
结果 切脾组手术时间、住院时间和膈下感染发生率均明显高于保脾组（P<0.05）。切脾组与保脾组术后病理检查出的第10、11组淋巴结转移率的差异无统计学意义（P>0.05）。
结论 进展期近端胃癌根治术时，脾脏和脾血管受侵是联合脾脏切除的合理适应证。
Abstract:
Objective  To investigate the reasonable indication of splenectomy in radical resection for advanced proximal gastric cancer (APGC).
Methods  Fifty patients with APGC were studied and classified into total gastrectomy with splenectomy (TGS) group (n=18) and total gastrectomy without splenectomy (TG) group (n=32). The operation time, hospitalized duration, complications, and lymphe node metastasis at the spleen hilus were compared between two groups. Results  The operation time, hospitalized duration and subphrenic infection rate in the TGS group were significantly higher than those in the TG group (P<0.05). The rate of lymph node metasitasis of No.10 and No.11 in the TG group was not different from that in TGS group (P>0.05).
Conclusion  Direct spleen and its vessel invasion are the reasonable indication of splenectomy in radical resection for APGC.

参考文献/References

 ［1］孙立波, 李永超, 冯野, 等. 全胃切除术后改良Orr式RouxenY 食管空肠吻合术的临床研究 ［J］. 中国普外基础与临床杂志, 2008; 15(12): 917919.
［2］Okinaga K, Iinuma H, Kitamura Y, et al. Effect of immunotherapy and spleen preservation on immunological function in patients with gastric cancer ［J］. J Exp Clin Cancer Res, 2006; 25(3): 339349.
［3］Noma K, Yamaguchi Y, Okita R, et al. The spleen plays an immunosuppressive role in patients with gastric cancer: involvement of CD62L+ cells and TGFbeta ［J］.Anticancer Res, 2005; 25(1B): 643649.
［4］Nanthakumaran S, Fernandes E, Thompson AM, et al. Morbidity and mortality rates following gastric cancer surgery and contiguous organ removal, a population based study ［J］. Eur J Surg Oncol, 2005; 31(10): 11411144.
［5］Biffi R, Chiappa A, Luca F, et al. Extended lymph node dissection without routine splenopancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients ［J］. J Surg Oncol. 2006; 93(5): 394400.
［6］Fatouros M, Roukos DH, Lorenz M, et al. Impact of spleen preservation in patients with gastric cancer ［J］. Anticancer Res, 2005; 25(4): 30233030.
［7］Zhang CH, Zhan WH, He YL, et al. Spleen preservation in radical surgery for gastric cardia cancer ［J］. Ann Surg Oncol, 2007; 14(4): 13121319.
［8］Shen JG, Cheong JH, Hyung WJ, et al. Adverse effect of splenectomy on recurrence in total gastrectomy cancer patients with perioperative transfusion ［J］. Am J Surg, 2006; 192(3): 301305.
［9］Kunisaki C, Makino H, Suwa H, et al. Impact of splenectomy in patients with gastric adenocarcinoma of the cardia ［J］. J Gastrointest Surg, 2007; 11(8): 10391044.
［10］Yu W, Choi GS, Chung HY. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer ［J］. Br J Surg, 2006; 93(5): 559563.
［11］Kunisaki C, Shimada H, Ono H, et al. Predictive factors for pancreatic fistula after pancreaticosplenectomy for advanced gastric cancer in the upper third of the stomach ［J］. J Gastrointest Surg, 2006; 10(1): 132137.
［12］McCulloch P, Niita ME, Kazi H, et al. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer ［J］. Br J Surg, 2005; 92(1): 513.
［13］Kikuchi S, Nemoto Y, Natsuya K, et al. Which patients with advanced, proximal gastric cancer benefit from complete clearance of splenopancreratic lymph nodes ［J］. Anticancer Res, 2002; 22(6B): 35133517.
［14］Weitz J, Jaques DP, Brennan M, et al. Association of splenectomy with postoperative complications in patients with proximal gastric and gastroesophageal junction cancer ［J］. Ann Surg Oncol, 2004; 11(7): 682689.
［15］Yamamoto M, Baba H, Kakeji Y, et al. Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer ［J］. Hepatogastroenterology, 2004; 51(55): 298302.
［16］Ohno M, Nakamura T, Ajiki T, et al. Procedure for lymph node dissection around splenic artery in proximal gastric cancer ［J］. Hepatogastroenterology, 2003; 50(52): 11731177.
［17］Carboni F, Lepiane P, Santoro R, et al. Extended multiorgan resection for T4 gastric carcinoma: 25year experience ［J］. J Surg Oncol, 2005; 90(2): 95100.
［18］Ikeguchi M, Kaibara N. Lymph node metastasis at the splenic hilum in proximal gastric cancer ［J］. Am Surg, 2004; 70(7): 645648.
［19］ Csendes A, Burdiles P, Rojas J, et al. A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma ［J］. Surgery, 2002; 131(4): 401407.
［20］Bisharat N, Omari H, Lavi L, et al. Risk of infection and death among postsplenectomy patients ［J］. J Infect, 2001; 43(3): 182186.
［21］Yang K, Chen XZ, Hu JK, et al. Effectiveness and safety of splenectomy for gastric carcinoma: a metaanalysis ［J］. World J Gastroenterol, 2009; 15(42): 53525359.
［22］Sasada S, Ninomiya M, Nishizaki M, et al. Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer ［J］. Anticancer Res, 2009; 29(8): 33473351.
［23］Oh SJ, Hyung WJ, Li C, et al. The effect of spleenpreserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer ［J］. J Surg Oncol, 2009; 99(5): 275280.
［24］何运胜, 姜淮芜. 进展期胃癌多模式治疗的研究进展 ［J］. 中国普外基础与临床杂志, 2008; 15(1): 3135.
［25］胡建昆, 陈志新, 张波, 等. 胃癌根治术中No. 8 淋巴结清扫的意义和技巧 ［J］. 中国普外基础与临床杂志, 2007; 14(5): 560563.

备注/Memo

备注/Memo:
 【通讯作者】孙立波，E-mail: sunlibo0431@sina.com
【作者简介】崔超（1980年-），男，吉林省敦化市人，硕士研究生，住院医师，主要研究方向为胃肠肿瘤性疾病，
E-mail: cuichao1109@163.com。
2009-11-08收稿, 2009-12-02修回
更新日期/Last Update: 2010-02-01